Thrivent Financial for Lutherans
ADMA icon

Thrivent Financial for Lutherans’s ADMA Biologics ADMA Stock Holding History

Thrivent Financial for Lutherans’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.27M Sell
152,197
-6,659
-4% -$60.7K ﹤0.01% 1846
2026
Q1 		$1.43M Sell
158,856
-3,631,662
-96% -$57.3M ﹤0.01% 1672
2025
Q4 		$69.1M Sell
3,790,518
-351,322
-8% -$5.92M 0.12% 194
2025
Q3 		$60.7M Buy
4,141,840
+826,415
+25% +$14.2M 0.12% 202
2025
Q2 		$60.4M Buy
3,315,425
+1,453,924
+78% +$29.6M 0.13% 189
2025
Q1 		$36.9M Buy
1,861,501
+1,673,881
+892% +$28.9M 0.08% 297
2024
Q4 		$3.22M Sell
187,620
-2,585
-1% -$48.6K 0.01% 1133
2024
Q3 		$3.8M Buy
+190,205
New +$2.96M 0.01% 1056
2021
Q2 		– Sell
-37,525
Closed -$66K – 2450
2021
Q1 		$66K Sell
37,525
-156,225
-81% -$358K ﹤0.01% 2512
2020
Q4 		$378K Hold
193,750
– – ﹤0.01% 2222
2020
Q3 		$463K Sell
193,750
-1,616
-0.8% -$4.43K ﹤0.01% 2006
2020
Q2 		$573K Hold
195,366
– – ﹤0.01% 1839
2020
Q1 		$563K Buy
+195,366
New +$675K ﹤0.01% 1654

Other funds holding ADMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Thrivent Financial for Lutherans's ADMA Position: Q2 2026 in Review

Thrivent Financial for Lutherans reduced its ADMA Biologics (ADMA) stake by 4.2% in Q2 2026, selling an estimated $60.7K and leaving 152,197 shares worth $1.27M. The position accounts for ﹤0.01% of the portfolio, ranked #1846.

Thrivent Financial for Lutherans first reported a position in ADMA in Q1 2020 and has held it in 13 quarters since. The position peaked at $69.1M in Q4 2025. 323 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.

  • Thrivent Financial for Lutherans held 152,197 shares of ADMA Biologics worth $1.27M as of Q2 2026.
  • Thrivent Financial for Lutherans sold 6,659 ADMA Biologics shares in Q2 2026, an estimated $60.7K.
  • ADMA Biologics made up ﹤0.01% of Thrivent Financial for Lutherans's portfolio in Q2 2026, its #1846 holding.
  • Thrivent Financial for Lutherans first reported a position in ADMA Biologics in Q1 2020 and has held it in 13 quarters since.
  • Thrivent Financial for Lutherans's ADMA Biologics position peaked at $69.1M in Q4 2025.
  • 323 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.

Based on Thrivent Financial for Lutherans's 13F filing for Q2 2026, filed 14 Aug 2026.